{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "9b0ddf6b-29fe-44b6-a6fd-75307250a72f",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "art = pd.read_csv('article_dat.csv')\n",
    "model = pd.read_csv('model_dat.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "aabf5fa5-b1b5-48c6-a1bc-5c8d51207467",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(                                doi                    outcome measure  \\\n",
       " count                          6762                       6762    6762   \n",
       " unique                          299                        983      83   \n",
       " top     10.1016/j.ygyno.2018.02.019  Primary Cesarean Delivery      OR   \n",
       " freq                            212                        176    1958   \n",
       " mean                            NaN                        NaN     NaN   \n",
       " std                             NaN                        NaN     NaN   \n",
       " min                             NaN                        NaN     NaN   \n",
       " 25%                             NaN                        NaN     NaN   \n",
       " 50%                             NaN                        NaN     NaN   \n",
       " 75%                             NaN                        NaN     NaN   \n",
       " max                             NaN                        NaN     NaN   \n",
       " \n",
       "                point         lower         upper  treatment_received  \\\n",
       " count   6.762000e+03   6564.000000   6536.000000         6555.000000   \n",
       " unique           NaN           NaN           NaN                 NaN   \n",
       " top              NaN           NaN           NaN                 NaN   \n",
       " freq             NaN           NaN           NaN                 NaN   \n",
       " mean    1.220538e+03     -2.232684      1.943068            0.522807   \n",
       " std     7.623489e+04   1315.406812   1377.439492            0.499518   \n",
       " min    -6.639580e+03  -6496.000000  -3161.000000            0.000000   \n",
       " 25%     9.400000e-01    -99.000000    -99.000000            0.000000   \n",
       " 50%     1.410000e+00      0.690000      1.140000            1.000000   \n",
       " 75%     1.000000e+01      1.100000      1.990000            1.000000   \n",
       " max     6.239314e+06  91767.000000  94979.000000            1.000000   \n",
       " \n",
       "         access_to_care subgrp stratgrp  \n",
       " count      6555.000000   1179     3382  \n",
       " unique             NaN    135      510  \n",
       " top                NaN   Race    Black  \n",
       " freq               NaN    103      141  \n",
       " mean          0.457361    NaN      NaN  \n",
       " std           0.498217    NaN      NaN  \n",
       " min           0.000000    NaN      NaN  \n",
       " 25%           0.000000    NaN      NaN  \n",
       " 50%           0.000000    NaN      NaN  \n",
       " 75%           1.000000    NaN      NaN  \n",
       " max           1.000000    NaN      NaN  ,\n",
       "                        point     lower     upper  treatment_received  \\\n",
       " point               1.000000  0.017107  0.175205            0.007904   \n",
       " lower               0.017107  1.000000  0.999239           -0.017550   \n",
       " upper               0.175205  0.999239  1.000000           -0.018900   \n",
       " treatment_received  0.007904 -0.017550 -0.018900            1.000000   \n",
       " access_to_care     -0.014638 -0.013107 -0.013080            0.195346   \n",
       " \n",
       "                     access_to_care  \n",
       " point                    -0.014638  \n",
       " lower                    -0.013107  \n",
       " upper                    -0.013080  \n",
       " treatment_received        0.195346  \n",
       " access_to_care            1.000000  )"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Merge the model and article datasets on 'doi'\n",
    "# merged_df = pd.merge(model, art, on='doi', how='left')\n",
    "# merged_df.to_csv('main.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "08a0bbf7-9c35-4e74-aae3-ca9ac8701aa8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(                            doi  model_number stratified  \\\n",
       " 0  10.1097/AOG.0000000000003552             1        Yes   \n",
       " 1  10.1097/AOG.0000000000003552             1        Yes   \n",
       " 2  10.1097/AOG.0000000000003552             1        Yes   \n",
       " 3  10.1097/AOG.0000000000003552             1        Yes   \n",
       " 4  10.1097/AOG.0000000000003552             1        Yes   \n",
       " \n",
       "                                             stratgrp subanalysis subgrp  \\\n",
       " 0  Achieved sterilization at time of cesarean del...          No    NaN   \n",
       " 1  Achieved sterilization at time of cesarean del...          No    NaN   \n",
       " 2  Achieved sterilization at time of cesarean del...          No    NaN   \n",
       " 3  Achieved sterilization at time of cesarean del...          No    NaN   \n",
       " 4  Achieved sterilization at time of cesarean del...          No    NaN   \n",
       " \n",
       "                                           outcome  measure measure_comments  \\\n",
       " 0  Sterilization at the time of cesarean delivery  Percent              NaN   \n",
       " 1  Sterilization at the time of cesarean delivery  Percent              NaN   \n",
       " 2  Sterilization at the time of cesarean delivery  Percent              NaN   \n",
       " 3  Sterilization at the time of cesarean delivery  Percent              NaN   \n",
       " 4  Sterilization at the time of cesarean delivery  Percent              NaN   \n",
       " \n",
       "   covariates  ...  other_gyn_onc endo fibroids  other_gyn_surg  fert  \\\n",
       " 0        NaN  ...            0.0  0.0      0.0             0.0   0.0   \n",
       " 1        NaN  ...            0.0  0.0      0.0             0.0   0.0   \n",
       " 2        NaN  ...            0.0  0.0      0.0             0.0   0.0   \n",
       " 3        NaN  ...            0.0  0.0      0.0             0.0   0.0   \n",
       " 4        NaN  ...            0.0  0.0      0.0             0.0   0.0   \n",
       " \n",
       "    matmorbmort  other_preg phys_div other  covid  \n",
       " 0          1.0         0.0      0.0   0.0    0.0  \n",
       " 1          1.0         0.0      0.0   0.0    0.0  \n",
       " 2          1.0         0.0      0.0   0.0    0.0  \n",
       " 3          1.0         0.0      0.0   0.0    0.0  \n",
       " 4          1.0         0.0      0.0   0.0    0.0  \n",
       " \n",
       " [5 rows x 80 columns],\n",
       " ['doi',\n",
       "  'model_number',\n",
       "  'stratified',\n",
       "  'stratgrp',\n",
       "  'subanalysis',\n",
       "  'subgrp',\n",
       "  'outcome',\n",
       "  'measure',\n",
       "  'measure_comments',\n",
       "  'covariates',\n",
       "  'comparison',\n",
       "  'ref',\n",
       "  'compare',\n",
       "  'point',\n",
       "  'lower',\n",
       "  'upper',\n",
       "  'pmid',\n",
       "  'jabbrv',\n",
       "  'journal',\n",
       "  'year',\n",
       "  'month',\n",
       "  'day',\n",
       "  'title',\n",
       "  'abstract',\n",
       "  'keywords',\n",
       "  'study_aim',\n",
       "  'study_location',\n",
       "  'study_year_start',\n",
       "  'study_year_end',\n",
       "  'study_type',\n",
       "  'data_source',\n",
       "  'race1',\n",
       "  'race1_ss',\n",
       "  'race2',\n",
       "  'race2_ss',\n",
       "  'race3',\n",
       "  'race3_ss',\n",
       "  'race4',\n",
       "  'race4_ss',\n",
       "  'race5',\n",
       "  'race5_ss',\n",
       "  'race6',\n",
       "  'race6_ss',\n",
       "  'race7',\n",
       "  'race7_ss',\n",
       "  'race8',\n",
       "  'race8_ss',\n",
       "  'eth1',\n",
       "  'eth1_ss',\n",
       "  'eth2',\n",
       "  'eth2_ss',\n",
       "  'eth3',\n",
       "  'eth3_ss',\n",
       "  'eth4',\n",
       "  'eth4_ss',\n",
       "  'eth5',\n",
       "  'eth5_ss',\n",
       "  'eth6',\n",
       "  'eth6_ss',\n",
       "  'eth7',\n",
       "  'eth7_ss',\n",
       "  'eth8',\n",
       "  'eth8_ss',\n",
       "  'access_to_care',\n",
       "  'treatment_received',\n",
       "  'health_outcome',\n",
       "  'cancer_ovarian',\n",
       "  'cancer_uterine',\n",
       "  'cancer_cervical',\n",
       "  'cancer_vulvar',\n",
       "  'other_gyn_onc',\n",
       "  'endo',\n",
       "  'fibroids',\n",
       "  'other_gyn_surg',\n",
       "  'fert',\n",
       "  'matmorbmort',\n",
       "  'other_preg',\n",
       "  'phys_div',\n",
       "  'other',\n",
       "  'covid'])"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv('main.csv')\n",
    "\n",
    "# Display the first few rows and the column names\n",
    "df.head(), df.columns.tolist()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "id": "83c6ee1f-bfe6-4212-b1ac-0b637dcc94db",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting rapidfuzz\n",
      "  Downloading rapidfuzz-3.12.2-cp312-cp312-win_amd64.whl.metadata (12 kB)\n",
      "Downloading rapidfuzz-3.12.2-cp312-cp312-win_amd64.whl (1.6 MB)\n",
      "   ---------------------------------------- 0.0/1.6 MB ? eta -:--:--\n",
      "   ---------------------------------------- 0.0/1.6 MB ? eta -:--:--\n",
      "   ---------------------------------------- 0.0/1.6 MB ? eta -:--:--\n",
      "   - -------------------------------------- 0.0/1.6 MB 326.8 kB/s eta 0:00:05\n",
      "   -- ------------------------------------- 0.1/1.6 MB 573.4 kB/s eta 0:00:03\n",
      "   -- ------------------------------------- 0.1/1.6 MB 595.3 kB/s eta 0:00:03\n",
      "   ---- ----------------------------------- 0.2/1.6 MB 748.1 kB/s eta 0:00:02\n",
      "   ---- ----------------------------------- 0.2/1.6 MB 748.1 kB/s eta 0:00:02\n",
      "   ------- -------------------------------- 0.3/1.6 MB 999.9 kB/s eta 0:00:02\n",
      "   -------- ------------------------------- 0.3/1.6 MB 873.8 kB/s eta 0:00:02\n",
      "   ----------- ---------------------------- 0.5/1.6 MB 1.1 MB/s eta 0:00:02\n",
      "   ------------- -------------------------- 0.6/1.6 MB 1.2 MB/s eta 0:00:01\n",
      "   ---------------- ----------------------- 0.7/1.6 MB 1.3 MB/s eta 0:00:01\n",
      "   ------------------- -------------------- 0.8/1.6 MB 1.4 MB/s eta 0:00:01\n",
      "   --------------------- ------------------ 0.9/1.6 MB 1.5 MB/s eta 0:00:01\n",
      "   ------------------------ --------------- 1.0/1.6 MB 1.5 MB/s eta 0:00:01\n",
      "   --------------------------- ------------ 1.1/1.6 MB 1.6 MB/s eta 0:00:01\n",
      "   ------------------------------ --------- 1.2/1.6 MB 1.7 MB/s eta 0:00:01\n",
      "   -------------------------------- ------- 1.3/1.6 MB 1.7 MB/s eta 0:00:01\n",
      "   ----------------------------------- ---- 1.4/1.6 MB 1.7 MB/s eta 0:00:01\n",
      "   -------------------------------------- - 1.6/1.6 MB 1.8 MB/s eta 0:00:01\n",
      "   ---------------------------------------  1.6/1.6 MB 1.8 MB/s eta 0:00:01\n",
      "   ---------------------------------------- 1.6/1.6 MB 1.7 MB/s eta 0:00:00\n",
      "Installing collected packages: rapidfuzz\n",
      "Successfully installed rapidfuzz-3.12.2\n"
     ]
    }
   ],
   "source": [
    "!pip install rapidfuzz"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 163,
   "id": "beaab814-76cf-4c68-a83e-098d3046b5b1",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import re\n",
    "from rapidfuzz import process\n",
    "\n",
    "# Lowercased standardized mapping\n",
    "race_standardization = {\n",
    "    'african american': 'Black or African American',\n",
    "    'african american or black': 'Black or African American',\n",
    "    'african american, non-hispanic': 'Black or African American',\n",
    "    'black': 'Black or African American',\n",
    "    'black or african american': 'Black or African American',\n",
    "    'black, non-hispanic': 'Black or African American',\n",
    "    'non african american': 'Black or African American',\n",
    "    'non-african american': 'Black or African American',\n",
    "    'non-hispanic black': 'Black or African American',\n",
    "\n",
    "    'caucasian': 'White',\n",
    "    'white': 'White',\n",
    "    'non hispanic white': 'White',\n",
    "    'non-hispanic white': 'White',\n",
    "    'non-latina white': 'White',\n",
    "    'white (non-hispanic)': 'White',\n",
    "    'white non-hispanic': 'White',\n",
    "    'white/caucasian': 'White',\n",
    "    'whites': 'White',\n",
    "    'u.s.-born, non-hispanic white;': 'White',\n",
    "    'non-hispanic, white': 'White',\n",
    "    'white donor / white recipient': 'White',\n",
    "    'european american': 'White',\n",
    "    'non hispanic whites': 'White',\n",
    "    'white, non-hispanic': 'White',\n",
    "\n",
    "    'hispanic': 'Hispanic or Latino',\n",
    "    'latina': 'Hispanic or Latino',\n",
    "    'latino': 'Hispanic or Latino',\n",
    "    'mexican/american': 'Hispanic or Latino',\n",
    "\n",
    "    'asian': 'Asian or Pacific Islander',\n",
    "    'asian, non-hispanic': 'Asian or Pacific Islander',\n",
    "    'asian american': 'Asian or Pacific Islander',\n",
    "    'pacific islander': 'Asian or Pacific Islander',\n",
    "\n",
    "    'american indian': 'American Indian or Alaska Native',\n",
    "    'american indian/alaska native': 'American Indian or Alaska Native',\n",
    "    'american indian/alaskan': 'American Indian or Alaska Native',\n",
    "    'american indian/alaskan native': 'American Indian or Alaska Native',\n",
    "    'native american': 'American Indian or Alaska Native',\n",
    "    'non-hispanic american indian or alaska native': 'American Indian or Alaska Native',\n",
    "\n",
    "    'minority': 'Other / Multiracial',\n",
    "    'nonwhite': 'Other / Multiracial',\n",
    "    'non-white': 'Other / Multiracial',\n",
    "    'urm (black, hispanic, native american/alaskan, asian/pacific islander, and other)': 'Other / Multiracial',\n",
    "    'other': 'Other / Multiracial',\n",
    "    'multiracial': 'Other / Multiracial',\n",
    "\n",
    "    'unknown': 'Unknown / Not Reported',\n",
    "    'not reported': 'Unknown / Not Reported'\n",
    "}\n",
    "\n",
    "def handle_compound_race(label):\n",
    "    if pd.isna(label):\n",
    "        return 'Unknown / Not Reported'\n",
    "\n",
    "    label = label.lower().strip()\n",
    "    label = re.sub(r'[;:,_]', '/', label)\n",
    "    label = re.sub(r'\\s*(and|or|/)\\s*', '/', label)\n",
    "    parts = [p.strip() for p in label.split('/') if p.strip()]\n",
    "\n",
    "    matched = set()\n",
    "    for part in parts:\n",
    "        if part in race_standardization:\n",
    "            matched.add(race_standardization[part])\n",
    "        else:\n",
    "            match, score, _ = process.extractOne(part, race_standardization.keys())\n",
    "            if score >= 90:\n",
    "                matched.add(race_standardization[match])\n",
    "\n",
    "    if not matched:\n",
    "        return 'Other / Multiracial'\n",
    "    elif len(matched) == 1:\n",
    "        return list(matched)[0]\n",
    "    else:\n",
    "        return 'Other / Multiracial'\n",
    "\n",
    "def standardize_race_labels(series, use_fuzzy=True, fuzzy_threshold=90):\n",
    "    def normalize(label):\n",
    "        if pd.isna(label):\n",
    "            return 'unknown'\n",
    "        return label.strip().lower()\n",
    "\n",
    "    def map_label(label):\n",
    "        if label in race_standardization:\n",
    "            return race_standardization[label]\n",
    "        if use_fuzzy:\n",
    "            match, score, _ = process.extractOne(label, race_standardization.keys())\n",
    "            if score >= fuzzy_threshold:\n",
    "                return race_standardization[match]\n",
    "        return handle_compound_race(label)\n",
    "\n",
    "    normalized_series = series.apply(normalize)\n",
    "    standardized_series = normalized_series.apply(map_label)\n",
    "\n",
    "    original_unmapped = series[~normalized_series.isin(race_standardization.keys())].unique()\n",
    "    if len(original_unmapped) > 0:\n",
    "        print(\"\\n⚠️ Unmapped race labels for review:\")\n",
    "        for label in original_unmapped:\n",
    "            print(f\"  - {label}\")\n",
    "\n",
    "    return standardized_series\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 165,
   "id": "c146bcc0-d913-45a1-97b8-4547aa6aefef",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "df['race1_clean'] = standardize_race_labels(df['race1'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "id": "b1592f31-eb6c-4349-a87d-f28ea891b9c2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Sterilization at the time of cesarean delivery',\n",
       " 'Nonachievement of sterilization at time of cesarean delivery',\n",
       " 'germline testing performed',\n",
       " 'Somatic testing performed',\n",
       " 'Germline testing performed',\n",
       " 'advanced ovarian cancer',\n",
       " 'endometrioid endometrial cancer survival',\n",
       " 'non-endometrioid endometrial cancer survival',\n",
       " 'Ovarian cancer trial accrual',\n",
       " 'Uterine cancer trial accrual',\n",
       " 'Cervical cancer trial accrual',\n",
       " 'All gynecological cancers',\n",
       " 'Uterine cancer trial accural',\n",
       " 'Cervical cancer trial accural',\n",
       " 'Difference in clinical trial accruals and population incidence for ovarian cancer',\n",
       " 'Difference in clinical trial accruals and population incidence for uterine cancer',\n",
       " 'likelihood of late treatment',\n",
       " 'all-cause mortality for patients diagnosed with uterine cancer',\n",
       " 'Sugery',\n",
       " 'Chemotherapy',\n",
       " 'Radiation',\n",
       " 'Overall mortality',\n",
       " 'Dying without Hospice',\n",
       " 'having a medical power of attorney or living will',\n",
       " 'Sexual activity',\n",
       " 'Sexual dysfunction in sexually active women',\n",
       " 'A Haplotype frequency',\n",
       " 'B Haplotype frequency',\n",
       " 'C Haplotype frequency',\n",
       " 'D Haplotype frequency',\n",
       " 'E Haplotype frequency',\n",
       " 'F Haplotype frequency',\n",
       " 'G Haplotype frequency',\n",
       " 'H Haplotype frequency',\n",
       " 'I Haplotype frequency',\n",
       " 'J Haplotype frequency',\n",
       " 'K Haplotype frequency',\n",
       " 'Presence of Haplotype A',\n",
       " 'Absence of Haplotype B',\n",
       " 'Presence of Haplotype C',\n",
       " 'Absence of Haplotype C',\n",
       " 'Presence of Haplotype D',\n",
       " 'Absence of Haplotype E',\n",
       " 'Presence of Haplotype F',\n",
       " 'Absence of Haplotype F',\n",
       " 'Presence of Haplotype G',\n",
       " 'Absence of Haplotype G',\n",
       " 'Presence of Haplotype H',\n",
       " 'Absence of Haplotype H',\n",
       " 'Presence of Haplotype I',\n",
       " 'Absence of Haplotype I',\n",
       " 'Presence of Haplotype J',\n",
       " 'Absence of Haplotype J',\n",
       " 'Presence of Haplotype K',\n",
       " 'Absence of Haplotype K',\n",
       " 'Presence of Haplotype BCF',\n",
       " 'Absence of Haplotype BCF',\n",
       " 'Presence of Haplotype DE',\n",
       " 'Absence of Haplotype DE',\n",
       " 'Eligible, not enrolled among patients with a trial available',\n",
       " 'Enrolled among patients with a trial available',\n",
       " 'Not eligible among patients with a trial available',\n",
       " 'Race of women with a trial available',\n",
       " 'Variables associated with trial eligibility/ineligibity',\n",
       " 'Race doctor',\n",
       " 'Patient race',\n",
       " 'Recall of screening discussion',\n",
       " 'Clear understanding that screening was optional',\n",
       " 'Correct recall of whether screening was done',\n",
       " 'Recall of diagnostic testing discussion',\n",
       " 'Clear understanding that diagnostic testing was optional',\n",
       " 'Correct recall of whether diagnostic testing was done',\n",
       " 'Seeking treatment for urinary incontinence in visits 7, 8, or 9',\n",
       " 'endometrial cancer survival',\n",
       " 'Mortality differences',\n",
       " '5 year disease specific survival',\n",
       " '5 year disease-specific survival',\n",
       " 'Preterm birth',\n",
       " 'Ovarian cancer treatment',\n",
       " 'ovarian cancer treatment',\n",
       " 'non-adherence to national comprehensive cancer network guidelines',\n",
       " 'contraceptive use: any method vs. no method',\n",
       " 'contraceptive use: highly/moderately vs. less-effective method',\n",
       " 'contraceptive use: highly vs. moderately/less-effective method',\n",
       " 'any method of contraceptive use',\n",
       " 'high/moderate vs least effective contraceptive',\n",
       " 'high vs moderate/least effective contraceptive',\n",
       " 'high vs moderate/least effective contracetive',\n",
       " 'Death from any cause',\n",
       " 'death from any cause',\n",
       " 'death from endometrial cancer',\n",
       " 'death from other causes',\n",
       " 'Antimullerian hormone levels',\n",
       " 'Contrasts between predicted geometric mean Antimullerian hormone (ng/mL) values',\n",
       " 'observed infant deaths resulting from anomalies',\n",
       " 'observed infant deaths resulting from anomalies/100,000',\n",
       " 'estimated differennce in nfant dealths resulting from anomalies',\n",
       " 'observed infant death with anomalies',\n",
       " 'estimated difference in mortality',\n",
       " 'preterm birth',\n",
       " 'diagnosed with invasive cervical cancer',\n",
       " 'Vaccination History',\n",
       " 'no vaccination history',\n",
       " 'Heard of HPV Vaccine (Yes)',\n",
       " 'heard of HPV Vaccine (No)',\n",
       " 'provider has talked with patient about vaccine (yes)',\n",
       " 'provider has talked with patient about vaccine (no)',\n",
       " 'vaccination before abnormal pap test result',\n",
       " 'vaccination in same month as abnormal pap test result',\n",
       " 'vaccination after abnormal pap test result',\n",
       " 'Persistent Bacterial Vaginosis',\n",
       " 'tumor recurrence rates',\n",
       " 'recurrence free survival',\n",
       " 'disease specific survival',\n",
       " '5-year overall survival',\n",
       " 'Infertility treatment use ($)',\n",
       " 'Cumulative pregnancy',\n",
       " 'Any pregnancy',\n",
       " 'Medications only vs. no treatment',\n",
       " 'IUI vs. no treatment',\n",
       " 'IVF vs. no treatment',\n",
       " '1-2 cycles vs. 0 cycles',\n",
       " '3-4 cycles vs. 0 cycles',\n",
       " '>= 5 cycles vs. 0 cycles',\n",
       " 'Mean cycle day',\n",
       " 'Presence of fibroid',\n",
       " 'Largest diameter of fibroid',\n",
       " 'Uterine volume',\n",
       " 'Endometrial thickness',\n",
       " 'Volume of right ovary',\n",
       " 'Volume of left ovary',\n",
       " 'Intention to provide abortion',\n",
       " 'Number of abortions done in residency rotation',\n",
       " 'Partial opt-out',\n",
       " 'Average abortion attitude score',\n",
       " 'Intention to provide abortion for any indication among us obstetrics and gynecology residents',\n",
       " 'Predictors of Brachytherapy',\n",
       " 'Duration of Radiation Therapy',\n",
       " 'Reason patient did not receive radiation therapy for treatment of cervical cancer',\n",
       " 'Overall Survival',\n",
       " 'Association between patient characteristics and missed opportunities',\n",
       " 'adjuvant radiotherapy',\n",
       " 'oncologic surgery',\n",
       " 'Death',\n",
       " 'Human papillomavirus vaccination rate',\n",
       " 'Difference of human papillomavirus vaccination rates before and after the mandate',\n",
       " 'initiation of the human papillomavirus vaccine series',\n",
       " 'Overall survival',\n",
       " 'Receiving standard of care therapy',\n",
       " 'Not receiving any radiotherapy boost',\n",
       " 'Cause-specific survival',\n",
       " 'Undergoing Minimally Invasive Surgery Compared with Open Surgery',\n",
       " 'Health Professional Shortage Area; Medically Underserved Areas/Populations',\n",
       " 'Poverty Greater than 20%',\n",
       " 'Rural',\n",
       " 'Need for 2nd line chemotherapy',\n",
       " 'Postpartum hemorrhage',\n",
       " 'Peripartum infection',\n",
       " 'Severe perineal laceration at spontaneous vaginal delivery',\n",
       " 'Labor induction',\n",
       " 'Dilation 2 cm or less at admission',\n",
       " 'Maximum oxytocin 20 milliunits/min or greater',\n",
       " '80% or more of labor augmented with oxytocin',\n",
       " '1 h or more between complete dilation and initiation of pushing',\n",
       " 'Less than 1 vaginal examination/every 3 h in 1st stage',\n",
       " 'Vaginal delivery',\n",
       " 'Episiotomy',\n",
       " 'General anesthesia at cesarean delivery',\n",
       " 'nonadherence to national comprehensive cancer network treatment guidelines',\n",
       " 'Ovarian Cancer-Specific Survival',\n",
       " 'Effect of Adherence and Nonadherence to National Comprehensive Cancer Network Treatment Guidelines on Ovarian Cancer–Specific Survival',\n",
       " 'Median Disease-Specific Survival Time',\n",
       " 'Ectopic Pregnancy',\n",
       " 'Unplanned cesarean delivery',\n",
       " 'Combined delivery',\n",
       " 'Elective cesarean delivery',\n",
       " 'Blood transfusion',\n",
       " 'NICU admission 32-36 wks',\n",
       " 'NICU >= 37 wks',\n",
       " 'national comprehensive cancer network adherent care',\n",
       " 'national comprehensive cancer network nonadherent care',\n",
       " 'Wound infection',\n",
       " 'Vaginal or pelvic infection',\n",
       " 'Sepsis or other infection',\n",
       " 'Anemia or hemorrhage',\n",
       " 'Thromboembolism',\n",
       " 'Heart failure or MI',\n",
       " 'Pulmonary',\n",
       " 'Gastrointestinal',\n",
       " 'Acute renal failure or insufficiency',\n",
       " 'Death from endometrial cancer',\n",
       " 'Death from other causes',\n",
       " 'Insurance coverage',\n",
       " 'patients receiving ovarian cancer related Surgical procedures',\n",
       " 'Hysterectomy',\n",
       " 'Lymphadenectomy',\n",
       " 'Bowel resection',\n",
       " 'Peritoneal excision',\n",
       " 'receiving treatment at a High volume hospital',\n",
       " 'Metabolic syndrome',\n",
       " 'BMI',\n",
       " 'TG',\n",
       " 'HDL',\n",
       " 'BP',\n",
       " 'Glucose',\n",
       " 'no hospice',\n",
       " 'late hospice',\n",
       " 'does not enroll in hospice',\n",
       " 'Uterine cancer death at 4 years',\n",
       " '4 year survival among surgical uterine cancer patients',\n",
       " 'Vaccination',\n",
       " 'Amount heard about 2009 H1N1 vaccine',\n",
       " 'Concern about self getting 2009 H1N1 in next 12 mo',\n",
       " 'Concern about baby getting 2009 H1N1 in next 12 mo after baby is born',\n",
       " 'Belief in greater risk of becoming seriously ill from 2009 H1N1 for pregnant women',\n",
       " 'Safety of vaccine for pregnant women',\n",
       " 'Benefit of vaccine to fetus',\n",
       " 'Recommendation from health care provider to get 2009 H1N1 vaccine while pregnant',\n",
       " 'Seasonal influenza vaccination',\n",
       " 'Mean cervical cancer survival',\n",
       " 'Cervical cancer survival',\n",
       " 'Individual level cervical cancer survival',\n",
       " 'Neighborhood level cervical cancer survival',\n",
       " 'C-reactive protein',\n",
       " 'Epstein-Barr virus antibodies',\n",
       " 'mortality from advanced ovarian cancer',\n",
       " 'Propensity matched cohorts',\n",
       " 'Live birth',\n",
       " 'Very early preterm birth (<29 weeks)',\n",
       " 'Early preterm birth (<32 weeks)',\n",
       " 'Preterm birth (<37 weeks)',\n",
       " 'Term birth (>=37 weeks)',\n",
       " 'Birth weight z-score <-1',\n",
       " 'Birth weight z-score <-2',\n",
       " 'Low Sexual Desire or Interest',\n",
       " 'Less than Monthly Sexual Activity',\n",
       " 'Low Sexual Satisfaction',\n",
       " 'human papillomavirus vaccination completion rates',\n",
       " 'Myomectomy',\n",
       " 'Hysteroscopic resection',\n",
       " 'Uterine artery embolization',\n",
       " 'Endometrial ablation',\n",
       " 'Thermal balloon',\n",
       " 'Very early spontaneous preterm birth: 20.0-27.9 weeks gestation',\n",
       " 'Early spontaneous preterm birth: 27.0-33.9 weeks gestation',\n",
       " 'Inadequate Gestational Weight Gain',\n",
       " 'Excessive Gestational Weight Gain',\n",
       " 'Standard treatment',\n",
       " 'Surgery',\n",
       " 'Radiotherapy',\n",
       " 'Disease-specific mortality',\n",
       " 'All-cause mortality',\n",
       " 'Receiving IP chemotherapy',\n",
       " 'Type ii endometrial cancer specific survival',\n",
       " 'overall survival',\n",
       " 'Vulvar cancer mortality',\n",
       " 'Five year survival rate',\n",
       " 'Ectopic pregnancy rate',\n",
       " 'Preterm delivery <37 weeks',\n",
       " 'All cause mortality',\n",
       " 'Ovarian cancer mortality',\n",
       " 'cesarean delivery',\n",
       " 'Minimally-invasive surgical approach',\n",
       " 'In-hospital mortality',\n",
       " 'High-volume surgeon',\n",
       " 'Self-reported barrier to infertility care: internet access',\n",
       " 'Self-reported barrier to infertility care: fertility tx insurance coverage',\n",
       " 'Self-reported barrier to infertility care: referral source',\n",
       " 'Self-reported barrier to infertility care: harder to get treatment because of',\n",
       " 'Self-reported barrier to infertility care: it was difficult to',\n",
       " 'Self-reported barrier to infertility care: ability to bear children rests on',\n",
       " 'Points of worry and concern in seeking infertility treatment: historic misuse of medical treatment in my community',\n",
       " 'Points of worry and concern in seeking infertility treatment: need to consider adoption as alternative first',\n",
       " 'Points of worry and concern in seeking infertility treatment: personal sense of \"failing\" to conceive',\n",
       " 'Points of worry and concern in seeking infertility treatment: social stigma of infertility',\n",
       " 'Points of worry and concern in seeking infertility treatment: disappointing spouse',\n",
       " 'Points of worry and concern in seeking infertility treatment: friends or family finding out about treatment',\n",
       " 'Points of worry and concern in seeking infertility treatment: using science or technology to conceive',\n",
       " 'Points of worry and concern in seeking infertility treatment: short term side effects',\n",
       " 'Points of worry and concern in seeking infertility treatment: long term side effects',\n",
       " 'Points of worry and concern in seeking infertility treatment: having twins',\n",
       " 'Points of worry and concern in seeking infertility treatment: having triplets or greater',\n",
       " 'Points of worry and concern in seeking infertility treatment: having a miscarriage',\n",
       " 'Points of worry and concern in seeking infertility treatment: having an ectopic pregnancy',\n",
       " 'Points of worry and concern in seeking infertility treatment: risk of birth defects',\n",
       " 'endometrial cancer',\n",
       " 'Colon resection',\n",
       " 'Excision/destruction peritoneum/abdomen',\n",
       " 'High volume surgeon',\n",
       " 'High volume hospital',\n",
       " 'Documented provider counseling about 17-alpha hydroxyroprogesterone caproate',\n",
       " 'Patient receipt of 17-alpha hydroxyroprogesterone caproate',\n",
       " 'Adherence to 17-alpha hydroxyprogesterone caproate protocol',\n",
       " 'cervical insufficiency',\n",
       " 'time to recurrence',\n",
       " 'Diabetes mellitus',\n",
       " 'hypertension',\n",
       " 'obesity',\n",
       " 'morbid obesity',\n",
       " 'charlson comorbidity score 1',\n",
       " 'charlson comorbidity score >= 2',\n",
       " 'Overall death',\n",
       " 'Disease-specific death',\n",
       " '5 year survival',\n",
       " 'survival',\n",
       " 'infertility diagnosis - tubal factor',\n",
       " 'infertility diagnosis - male factor',\n",
       " 'infertility diagnosis - endometriosis',\n",
       " 'infertility diagnosis - anovulation',\n",
       " 'infertility diagnosis - unexplained',\n",
       " 'clinical pregnancy rate',\n",
       " 'live birth rate',\n",
       " 'complicated vaginal delivery',\n",
       " 'complicated cesarean delivery',\n",
       " 'obstetric trauma',\n",
       " 'blood transfusion',\n",
       " 'other obstetric complications',\n",
       " 'obstetric wound complications postvaginal delivery',\n",
       " 'obstetric wound complications postcesarean delivery',\n",
       " 'puerperal infection',\n",
       " 'postpartum urinary tract infection',\n",
       " 'peripartum hysterectomy if patients had PPH',\n",
       " 'postpartum vascular complications',\n",
       " 'obstetric thrombosis or embolism',\n",
       " 'uterine rupture if patients had trial of labor',\n",
       " 'puerperal cerebovascular disorders if patients had HDP',\n",
       " 'in hospital mortality',\n",
       " 'rating concern about using hormones long term” as “very important” in sterilization decisions',\n",
       " 'rating prior unwanted pregnancy” as “very important” in sterilization decisions',\n",
       " 'rating didn’t want foreign object in body (ie. iud or implant)” as “very important” in sterilization decisions',\n",
       " 'rating other methods decreased sexual pleasure” as “very important” in sterilization decisions',\n",
       " 'rating likelihood of family members with ts” as “very important” in sterilization decisions',\n",
       " 'rating mother most influential person in sterilization decision” as “very important” in sterilization decisions',\n",
       " 'rating doctor most influential person in sterilization decision” as “very important” in sterilization decisions',\n",
       " 'odds of answering ts reversal can easily restore fertility” correctly',\n",
       " 'odds of answering ts will reverse itself after 5 years” correctly',\n",
       " 'odds of answering a man can still ejaculate after vasectomy” correctly',\n",
       " 'odds of answering ovaries and uterus are removed during sterilization” correctly',\n",
       " 'Have ever heard of IUDS',\n",
       " 'open compared with minimally invasive surgery',\n",
       " 'Likelihood of diagnosis with advanced stage',\n",
       " 'Increased Hazard of Death Within 5 Years Among Patients with Advanced Stage Disease',\n",
       " 'Increased Hazard of Death Within 5 Years Among Patients with Advanced Stage Disease who underwent surgical treatment',\n",
       " '5-year all cause mortality',\n",
       " 'localized cervical cancer',\n",
       " 'regional cervical cancer',\n",
       " 'distant cervical cancer',\n",
       " 'unstaged cervical cancer',\n",
       " 'cervical cancer',\n",
       " 'cervical squamous cell carcinoma',\n",
       " 'cervical adenocarcinoma',\n",
       " 'Total Endometrial cancer',\n",
       " 'Low Risk Endometrial cancer',\n",
       " 'High Risk Endometrial cancer',\n",
       " 'Serous Endometrial cancer',\n",
       " 'Carcinosarcoma Endometrial cancer',\n",
       " 'Endometrial G3 cancer',\n",
       " 'Other and mixed Endometrial cancer',\n",
       " 'Primary Cesarean Delivery',\n",
       " 'Time to treatment initiation',\n",
       " 'Prolonged time to treatment initiation',\n",
       " 'peripartum hysterectomy',\n",
       " 'stage 3/4 endometrial cancer at diagnosis',\n",
       " 'inferior stage 3/4 overall survival',\n",
       " 'endometrial cancer mortality',\n",
       " 'endometrial cancer 2-year survival',\n",
       " 'endometrial cancer 2-year survival difference',\n",
       " 'endometrial cancer 5-year survival',\n",
       " 'endometrial cancer 5-year survival difference',\n",
       " 'Primary cesarean delivery',\n",
       " 'overall surviva',\n",
       " 'endometrial cancer five-year survival',\n",
       " \"preterm delivery at 37 weeks' gestation\",\n",
       " 'median survival',\n",
       " 'vaginal cancer survival',\n",
       " 'triglyceride levels (>= 150 mg/dL)',\n",
       " 'high density lipoprotein cholesterol levels (<= 50 mg/dL)',\n",
       " 'blood pressure (mm Hg >= 130/85 mm Hg)',\n",
       " 'glucose (>= 100 mg/dL)',\n",
       " 'metabolic syndrome',\n",
       " 'Utilization of Complementary and Alternative Treatment',\n",
       " 'BMI cut-off value sensitivity',\n",
       " 'BMI cut-off value specificity',\n",
       " 'actual obesity rate based on WHO criterion standard',\n",
       " \"obesity rate based on NIH's BMI cut off value\",\n",
       " 'obesity rate based on rate/ethnicity specific BMI cut off value',\n",
       " 'mean age at menopause',\n",
       " 'mortality',\n",
       " 'median overall survival',\n",
       " 'disease specific mortality',\n",
       " 'baseline BMI',\n",
       " 'progression free survival',\n",
       " 'death for all stages',\n",
       " 'early stage disease',\n",
       " 'difficulty with arousal',\n",
       " 'difficulty with lubrication',\n",
       " 'difficulty with orgasm',\n",
       " 'pain/discomfort with intercourse',\n",
       " 'five year survival rate',\n",
       " 'assisted reproduction technology outcomes',\n",
       " 'not achieving a live birth',\n",
       " 'histology: endometrioid',\n",
       " 'histology: non-endometrioid',\n",
       " 'histology: unknown',\n",
       " 'stage: local',\n",
       " 'stage: regional',\n",
       " 'stage: distant',\n",
       " 'stage: unknown',\n",
       " 'grade: well differentiated',\n",
       " 'grade: moderately differentiated',\n",
       " 'grade: poorly differentiated',\n",
       " 'grade: undifferentiated',\n",
       " 'grade: unknown',\n",
       " 'severe maternal morbidity with blood transfusion',\n",
       " 'severe maternal morbidity without blood transfusion',\n",
       " 'disseminated intravascular coagulation',\n",
       " 'heart failure during procedure or surgery',\n",
       " 'stillbirth',\n",
       " 'no surgery',\n",
       " 'removal of ovary +/- hysterectomy',\n",
       " 'debulking',\n",
       " 'no chemotherapy - “other” reason',\n",
       " 'no chemotherapy despite recommendation',\n",
       " 'cardiovascular pregnancy-related deaths',\n",
       " 'severe maternal morbidity',\n",
       " 'discussed incontinence with a clinician',\n",
       " 'discussed incontinence with a specialist',\n",
       " 'sought treatment in <1 year',\n",
       " 'provider recommended behavioral treatment for urinary incontinence',\n",
       " 'provider recommended pharmacologic treatment for urinary incontinence',\n",
       " 'previable live birth at 16 0/7 to 22 6/7 weeks of gestational age',\n",
       " 'ovarian yolk sac tumor patients',\n",
       " 'severe maternal morbidity without hospital characteristics',\n",
       " 'severe maternal morbidity with hospital characteristics',\n",
       " 'total preterm birth',\n",
       " 'spontaneous preterm birth',\n",
       " 'medically indicated preterm birth',\n",
       " 'overall pregestational diabetes mellitus',\n",
       " 'pregestational type 1 diabetes mellitus',\n",
       " 'pregestational type 2 diabetes mellitus',\n",
       " 'respiratory distress syndrome',\n",
       " 'sepsis',\n",
       " 'telomere length, as represented by the t/s ratio',\n",
       " 'placental tissue telomere length, as represented by the t/s ratio',\n",
       " 'amnion placental tissue telomere length',\n",
       " 'cord placental tissue telomere length',\n",
       " 'villus placental tissue telomere length',\n",
       " 'pregnancy rate',\n",
       " 'minimally invasive procedure use',\n",
       " 'postoperative complications',\n",
       " 'association of race/ethnicity with question responses regarding contraceptive preferences and attitudes - preferences (extremely important): method effectiveness',\n",
       " 'association of race/ethnicity with question responses regarding contraceptive preferences and attitudes - preferences (extremely important): low cost',\n",
       " 'association of race/ethnicity with question responses regarding contraceptive preferences and attitudes - preferences (extremely important): easy to use',\n",
       " 'association of race/ethnicity with question responses regarding contraceptive preferences and attitudes - preferences (extremely important): does not contain hormones',\n",
       " 'association of race/ethnicity with question responses regarding contraceptive preferences and attitudes - preferences (extremely important): acceptable to my partner',\n",
       " 'receipt of any postpartum care among low-income women ages 15-44 years delivering in california adjusted for select covariates, 2012',\n",
       " 'receipt of any postpartum contraception within 99 days, 2012',\n",
       " 'complications among surgery (salpingectomy or salpingostomy) patients',\n",
       " 'preterm infant delivery < 34 weeks',\n",
       " 'preterm infant delivery 34-36 weeks',\n",
       " 'spontaneous preterm infant delivery < 34 weeks',\n",
       " 'all minimally invasive hysterectomies (includes vaginal, laparoscopic, and robot-assisted hysterectomies) vs. abdominal hysterectomy',\n",
       " 'vaginal hysterectomy vs. abdominal hysterectomy',\n",
       " 'laparoscopic vs. abdominal hysterectomy',\n",
       " 'robot-assisted hysterectomy vs abdominal hysterectomy',\n",
       " 'all minimally invasive hysterectomies (includes vaginal, laparoscopic, and robot-assisted hysterectomies) vs abdominal hysterectomy',\n",
       " 'severe morbidity among women with postpartum hemorrhage',\n",
       " 'risk for severe morbidity (including transfusion)',\n",
       " 'risk for disseminated intravascular coagulation',\n",
       " 'association between race and adjuvent treatment in the nrg oncology/gynecologic oncology group 210 study, stratified by tumor subtype',\n",
       " 'recognition and evaluation of postmenopausal bleeding and at least 1 diagnostic procedure',\n",
       " 'recognition and evaluation of postmenopausal bleeding with no procedures',\n",
       " 'classified with ab codes',\n",
       " 'no documented bleeding with at least 1 diagnostic procedure',\n",
       " 'neither bleeding nor diagnostic procedures',\n",
       " 'nugent score, mean',\n",
       " 'severe morbidity during postpartum readmissions',\n",
       " 'postpartum blood pressure ascertainment',\n",
       " 'travel distance over time based on sociodemographic characteristics',\n",
       " 'travel distance based on sociodemographic characteristics',\n",
       " 'logistic regression model of the association between respondent demographics and residency program characteristics with low lac insertion experience among pgy4 residents',\n",
       " 'logistic regression model of the association between respondent demographics and residency program characteristics with low larc insertion experience among pgy4 residents',\n",
       " 'total severe maternal morbidity',\n",
       " 'severe maternal morbidity excluding cases with transfusion alone',\n",
       " 'racial difference in adherence to quality metrics - q1, time to surgery <6 weeks of diagnosis',\n",
       " 'racial difference in adherence to quality metrics - q2, minimally invasive surgery',\n",
       " 'racial difference in adherence to quality metrics - q3, pelvic lymphadenectomy',\n",
       " 'racial difference in adherence to quality metrics - q4, adjuvant radiotherapy',\n",
       " 'racial difference in adherence to quality metrics - q5, chemotherapy for stage iii/iv disease',\n",
       " 'severe meternal morbidity',\n",
       " 'odds ratios for associations between epidemiological and tumor characteristics and guideline-concordant treatment in the overall study population',\n",
       " 'odds ratios for associations between epidemiological and tumor characteristics and guideline-concordant treatment in overall study population',\n",
       " 'hazard rations for associations between guideline-concordant treatment and overall survival in the overall population and stratified by race/ethnicity',\n",
       " 'hazard ratios for associations between guideline-concordant treatment and overall survival in the overall population and stratified by race/ethnicity',\n",
       " 'associations between race/ethnicity and history of any unintended pregnancy',\n",
       " 'associations between race/ethnicity and any contraceptive use at last sex',\n",
       " 'rate of administration of antenatal corticosteroids',\n",
       " 'abnormal pap test by pap test alone or cotesting',\n",
       " 'abnormal hpv test',\n",
       " 'abnormal hpv and pap tests',\n",
       " 'positive pregnancy test',\n",
       " 'live birth',\n",
       " 'contacting a papanicolaou test referral before 1 month of follow-up',\n",
       " 'in need of cervical cancer screening at baseline',\n",
       " 'maternal in-hospital mortality',\n",
       " 'model-based average adjusted predictions of patient responses on visual analog scales expressing agreement with the following statement: “in general, the ability to bear children rests on timing/age',\n",
       " 'model-based average adjusted predictions of patient responses on visual analog scales expressing agreement with the following statement: “in general, the ability to bear children rests on stress',\n",
       " \"model-based average adjusted predictions of patient responses on visual analog scales expressing agreement with the following statement: “in general, the ability to bear children rests on god's will\",\n",
       " 'model-based average adjusted predictions of patient responses on visual analog scales expressing agreement with the following statement: “in general, the ability to bear children rests on biology/physiology',\n",
       " 'model-based average adjusted predictions of patient responses on visual analog scales expressing agreement with the following statement: “in general, the ability to bear children rests on chance',\n",
       " 'cervical length cutoff < 15 mm',\n",
       " 'cervical length cutoff < 25 mm',\n",
       " 'cervical length cutoff > 30 mm',\n",
       " 'funneling',\n",
       " 'debris',\n",
       " 'total pregnancy-related mortality ratio',\n",
       " 'pregnancy-related mortality ratio',\n",
       " 'cesarean section deliveries',\n",
       " 'admitted to adult intensive care unit',\n",
       " 'pregnancy-related mortality ratios for florida',\n",
       " 'abdominal sacrocolpopexy vs vaginal colpopexy for treatment of apical prolapse by race and ethnicity',\n",
       " 'laparoscopic vs open (laparotomy) abdominal sacrocolpopexy by race and ethnicity',\n",
       " '30-day postoperative complications - blood transfusion',\n",
       " '30-day postoperative complications - deep venous thrombosis and pulmonary embolism',\n",
       " '30-day postoperative complications - urinary tract infection',\n",
       " 'bilateral oophorectomy alone in 2011',\n",
       " 'hysterectomy with bilateral oophorectomy in 2011',\n",
       " 'overall bilateral oophorectomy in 2011',\n",
       " 'bilateral oophorectomy alone in 2012',\n",
       " 'hysterectomy with bilateral oophorectomy in 2012',\n",
       " 'methotrexate treatment failure of ectopic pregnancy',\n",
       " 'required public assistance',\n",
       " 'tubal rupture',\n",
       " 'clinical pregnancy',\n",
       " 'spontaneous abortion',\n",
       " 'multiple pregnancy',\n",
       " 'larc use vs. larc nonuse',\n",
       " 'larc use vs. high-efficacy use',\n",
       " 'larc use vs. low-efficacy use',\n",
       " 'received fertility counseling',\n",
       " 'not receiving fertility counseling',\n",
       " 'rates of accessing infertility care among women who reported infertility by respondent characteristics',\n",
       " 'assisted reproductive techonology births',\n",
       " 'gonadotropin dose >4,000 iu',\n",
       " 'cycle cancellation',\n",
       " 'hyperstimulation',\n",
       " 'total no. of oocytes retrieved/poisson beta coefficient for no. of oocytes retrieved',\n",
       " 'percentage of mature oocytes (does not include those who had their cycle cancelled or had no oocytes retrieved)',\n",
       " 'cancer specific survival',\n",
       " 'overal survival',\n",
       " 'low-volume hospital care',\n",
       " 'low-volume physician',\n",
       " 'unknown physician volume',\n",
       " 'high-volume hospital/low-volume physician',\n",
       " 'low-volume hospital/high-volume physician',\n",
       " 'progression-free survival',\n",
       " 'progression-free survival by racial genetic admixture',\n",
       " 'lymph node assessment',\n",
       " 'chemotherapy',\n",
       " 'radiation',\n",
       " 'surgery',\n",
       " 'five-year survival',\n",
       " '5-year disease-specific survival',\n",
       " 'chemotherapy radiation with concurrent chemoradiation',\n",
       " 'satisfaction with interpersonal manner of physician',\n",
       " 'satisfaction with accessibility and convenience of care',\n",
       " 'patient satisfaction',\n",
       " 'initial yes to randomized trials questionnaire',\n",
       " 'yes to randomized trials questionnaire after additional education',\n",
       " 'no to randomized trials questionnaire after additional education',\n",
       " 'unsure about randomized trials questionnaire after education',\n",
       " 'imrt usage',\n",
       " 'primary debulking surgical management type',\n",
       " 'interval debulking surgical management type',\n",
       " 'optimal debulking status',\n",
       " 'iv chemo',\n",
       " 'relative odds of type ii endometrial cancer among women in florida - type 2 (all)',\n",
       " 'relative odds of type ii endometrial cancer among women in florida',\n",
       " 'medical comorbidities of white and black women undergoing any hysterectomy and laparoscopic hysterectomy',\n",
       " 'received genetic counseling referrals',\n",
       " 'did not receive genetic counseling referrals',\n",
       " 'of referred patients, counseled',\n",
       " 'of referred patients, not counseled',\n",
       " 'adjusted progression free survival analysis',\n",
       " 'adjusted overall survival analysis',\n",
       " 'early stage mortality',\n",
       " 'advanced stage mortality',\n",
       " 'survival rate',\n",
       " 'receiving brachytherapy radiation boost',\n",
       " 'receiving external beam radiation radiation boost',\n",
       " 'receiving brachytherapy boost',\n",
       " 'cervical cancer mortality',\n",
       " 'all-cause mortality',\n",
       " 'receipt of surgery and chemotherapy',\n",
       " 'klabunde-modified charlson comorbidity score of 0',\n",
       " 'klabunde-modified charlson comorbidity score of 1',\n",
       " 'klabunde-modified charlson comorbidity score of 2',\n",
       " 'missing grade',\n",
       " 'hospice unenrollment prior to death',\n",
       " 'sample mean of implicit association test d-scores',\n",
       " 'have you heard of brca testing? - adjusted odds ratio for positive response',\n",
       " 'would you be interested in brca testing? adjusted odds ratio for positive response',\n",
       " 'have you heard of brca testing? adjusted odds ratio for positive response',\n",
       " 'brachytherapy use',\n",
       " 'brachytherapy administered',\n",
       " 'prognostic factor analysis in surgically managed vulvar cancer patients overall',\n",
       " 'prognostic factor analysis in surgically managed vulvar cancer patients by age cohort',\n",
       " 'survival analysis for low-grade serous carcinoma',\n",
       " 'risk of death',\n",
       " 'willingness to participate before and after educational intervention',\n",
       " 'change in willingness to participate',\n",
       " 'received guideline-concordant treatment',\n",
       " 'death',\n",
       " 'age-adjusted cervical cancer incidence rates (per 100,000)',\n",
       " 'age-adjusted uterine cancer incidence rates (per 100,000)',\n",
       " 'age-adjusted ovarian cancer incidence rates (per 100,000)',\n",
       " 'age-adjusted other gynecologic cancer incidence rates (per 100,000)',\n",
       " 'risk of conversion to open surgery for patients undergoing adequate minimally invasive staging for t1nxm0 endometrial carcinoma',\n",
       " 'percent adequacy of lymph node assessment in patients with t1nxm0 endometrial carcinoma undergoing minimally invasive surgical staging',\n",
       " 'endometrial hyperplasia symptoms',\n",
       " 'five-year hazard ratios of death associated with treatment adherence status',\n",
       " 'five-year overall survival associated with treatment adherence status',\n",
       " '% urm',\n",
       " '% hbno',\n",
       " '% asian/pi',\n",
       " 'utilization of palliative care among ovarian cancer patients',\n",
       " 'receipt of adjuvant radiation',\n",
       " 'annual percent change in the hysterectomy- and pregnancy- corrected incidence rates of uterine cancer',\n",
       " 'implantation',\n",
       " 'ectopic pregnancy complications',\n",
       " 'transfusion',\n",
       " 'mode of hysterectomy (laparoscopic, robotic, or vaginal hysterectomy compared with abdominal hysterectomy)',\n",
       " '30-day readmission',\n",
       " \"u.s. women's use of long-acting reversible contraception methods\",\n",
       " 'women who have ever discontinued a long-acting reversible contraception method as a result of dissatisfaction among those women who have ever used long-acting reversible contraception by selected demographic characteristics',\n",
       " 'nonadherence to national comprehensive cancer network treatment guidelines for locally advanced cervical cancer',\n",
       " 'overall survival based on the cox proportional hazard model',\n",
       " 'hispanic-white disparity in severe maternal morbidity',\n",
       " 'low-birth-weight among singletons conceived with assisted reproductive technology among florida, massachusetts, and michigan residents, by maternal race and ethnicity, 2000-2010',\n",
       " 'low-birth-weight among singletons conceived with assisted reproductive technology',\n",
       " 'low-birth-weight among singletons conceived without assisted reproductive technology',\n",
       " 'low-birth-weight among singletons conceived without assistive reproductive technology',\n",
       " 'preterm births among singletons conceived with assisted reproductive technology',\n",
       " 'pregnancy-related mortality',\n",
       " 'odds of cesarean delivery by maternal race in the nulliparous cohort',\n",
       " 'odds of cesarean delivery by maternal race and ethnicity in the nulliparous cohort',\n",
       " 'odds of cesarean delivery by maternal race and ethnicity in the multiparous cohort',\n",
       " 'postterm death',\n",
       " 'meconium-stained amniotic fluid',\n",
       " 'meconium aspiration syndrome',\n",
       " 'apgar score at 5 min <7',\n",
       " 'any preterm birth',\n",
       " 'medically-indicated preterm birth',\n",
       " 'hypertensive disease of pregnancy',\n",
       " 'small-for-gestational-age birth',\n",
       " 'correlation coefficients between state-specific maternal demographic and maternal mortality in the united states, 2005-2014',\n",
       " 'adherence to national comprehensive cancer network treatment guidelines in treatment recieved',\n",
       " 'receipt of nccn guideline-adherent care',\n",
       " 'nccn guideline-adherent care',\n",
       " 'cervical cancer-specific mortality',\n",
       " 'or time min; surgical morbidity after abdominal myomectomy',\n",
       " 'surgical site infection',\n",
       " 'wound dehiscence',\n",
       " 'composite morbidity after abdominal myomectomy',\n",
       " 'prevalence of human papillomavirus vaccine series completion',\n",
       " 'human papillomavirus vaccine series completion associated with race and ethnicity among females aged 11–26 years',\n",
       " 'severe maternal morbidity per 10,000 delivery hospitalizations',\n",
       " 'severe maternal morbidity without blood transfusion per 10,000 delivery',\n",
       " 'severe maternal morbidity per 10,000 delivery hospitalizations by comorbidity and race/ethnicity',\n",
       " 'open hysterectomy',\n",
       " 'complications',\n",
       " 'complication',\n",
       " 'association among race and ethnicity and number of pain assessments',\n",
       " 'association among race and ethnicity and receipt of oxycodone tablet equivalents',\n",
       " 'association among race and ethnicity and receipt of nonsteroidal antiinflammatory drugs',\n",
       " 'pain score 5 or higher',\n",
       " 'opioid prescription at discharge',\n",
       " 'preventable pregnancy-related death',\n",
       " 'disease-specific survival for sociodemographic variables',\n",
       " 'access to centers with high observed/expected ratios',\n",
       " 'severe maternal morbidity with blood transfusion cases',\n",
       " 'severe maternal morbidity without blood transfusion cases',\n",
       " 'multivariable logistic regression model of selected factors associated with cesarean delivery after labor induction',\n",
       " 'insurance status by race-ethnicity',\n",
       " 'composite neonatal adverse outcome',\n",
       " 'apgar score less than 5 at 5 min',\n",
       " 'relative risks of postnatal life support',\n",
       " 'relative risk of postnatal life support',\n",
       " 'risks of postnatal life support',\n",
       " 'composite maternal adverse outcome',\n",
       " 'unadjusted logistic regressions for associations between patient-level and hospital-level characteristics and maternal morbidity measures',\n",
       " 'adjusted logistic regressions for associations between patient-level and hospital-level characteristics and maternal morbidity measures',\n",
       " 'severe maternal morbidity potentially preventable',\n",
       " 'severe maternal morbidity not preventable, improvement needed',\n",
       " 'severe maternal morbidity any improvement needed',\n",
       " 'association between race and risk for major depression 30 days after medical management of early pregnancy loss',\n",
       " 'association between race and high perceived stress 30 days after medical management of early pregnancy loss',\n",
       " 'receiving national comprehensive cancer network guideline–adherent treatment for gynecologic cancer',\n",
       " 'receiving national comprehensive cancer network guideline–adherent treatment for gynecologic cancers',\n",
       " 'risk factors for failure to rescue from severe maternal morbidity',\n",
       " 'excess severe maternal morbidity',\n",
       " 'associated number of severe maternal morbidity cases',\n",
       " 'decline in ectopic pregnancy mortality ratio',\n",
       " 'ectopic pregnancy mortality',\n",
       " 'average annual decline in ectopic pregnancy mortality ratio during 1980–2007',\n",
       " 'overall projected decline in ectopic pregnancy mortality ratio between 2003–2007 and 2013–2017',\n",
       " 'neonatal death',\n",
       " 'postneonatal death',\n",
       " 'pregnancy-related mortality risk ratios by race, hispanic ethnicity, and nativity in the united states, 1993-2006',\n",
       " 'cesarean delivery (denominator is all deliveries)',\n",
       " 'primary cesarean delivery (denominator is all deliveries)',\n",
       " 'vaginal birth after cesarean, uncomplicated (denominator is previous cesarean)',\n",
       " 'vaginal birth after cesarean, all (denominator is previous cesarean)',\n",
       " 'cardiovascular severe maternal morbidity at delivery',\n",
       " 'postpartum cardiovascular severe maternal morbidity',\n",
       " 'Maternal In-Hospital Death',\n",
       " 'Expected Maternal In-Hospital Death',\n",
       " 'Agreement with the statement regarding the effect of timing/age on the ability to bear children',\n",
       " 'Agreement with the statement regarding the effect of stress on the ability to bear children',\n",
       " \"Agreement with the statement regarding the effect of God's will on the ability to bear children\",\n",
       " 'Agreement with the statement regarding the effect of biology/physiology on the ability to bear children',\n",
       " 'Agreement with the statement regarding the effect of chance on the ability to bear children',\n",
       " 'Cervical length < 15 mm',\n",
       " 'Cervical length < 25 mm',\n",
       " 'Cervical length < 30 mm',\n",
       " 'Cervical funneling',\n",
       " 'Intraamniotic debris',\n",
       " 'Pregnancy-related mortality',\n",
       " 'Any medication to treat opioid use disorder in the year after delivery',\n",
       " 'Any buprenorphine to treat opioid use disorder in the year after delivery',\n",
       " 'Methadone only to treat opioid use disorder in the year after delivery',\n",
       " 'Abdominal sacrocolpopexy',\n",
       " 'Laparoscopic',\n",
       " 'deep venous thrombosis and pulmonary embolism',\n",
       " 'urinary track infection',\n",
       " 'Clavien-Dindo complication grade II',\n",
       " 'bilateral oophorectomy alone',\n",
       " 'hysterectomy with bilateral oophorectomy',\n",
       " 'overall bilateral oophorectomy',\n",
       " 'hysterectomy with oophorectomy',\n",
       " 'Tone of recommendation letters for medical school applicants - Analytical thinking',\n",
       " 'Tone of recommendation letters for medical school applicants - Clout',\n",
       " 'Tone of recommendation letters for medical school applicants - Authenticity',\n",
       " 'Tone of recommendation letters for medical school applicants - Emotional',\n",
       " 'Intraoperative complication',\n",
       " 'Postoperative surgical complications',\n",
       " 'Postoperative complications',\n",
       " 'No complications',\n",
       " '>=5 Complications',\n",
       " 'Adjuvant treatment received',\n",
       " 'treatment delay of adjuvant treatment among patients who survived at least 3 months',\n",
       " 'No adjuvant treatment',\n",
       " 'treatment delay',\n",
       " 'Death > 3 months and within one year',\n",
       " 'Death >1 to 5 years',\n",
       " 'Surgical procedure for endometriosis - Laparoscopic excision or fulguration of pelvic lesions',\n",
       " 'Surgical procedure for endometriosis - Ureterolysis',\n",
       " 'Surgical procedure for endometriosis - Ovarian cyst drainage',\n",
       " 'Surgical procedure for endometriosis - Ovarian cystectomy',\n",
       " 'Surgical procedure for endometriosis - Oophorectomy',\n",
       " 'Surgical procedure for endometriosis - Salpingectomy or tubal ligation',\n",
       " 'Surgical procedure for endometriosis - Myomectomy',\n",
       " 'Surgical procedure for endometriosis - Hysterectomy',\n",
       " 'Laparotomy',\n",
       " 'Composite perioperative complication',\n",
       " 'Oophorectomy performed during endometriosis surgery',\n",
       " 'Minimally Invasive Myomectomy for Uterine Leiomyomas',\n",
       " 'Refusal of adjuvant radiation',\n",
       " 'Refusal of chemotherapy',\n",
       " 'low birthweight',\n",
       " 'Willingness to share maternal genetic data with academic researchers for non-clinical purposes',\n",
       " 'Willingness to share maternal genetic data with a government-funded medical research database for non-clinical purposes',\n",
       " 'Willingness to share maternal genetic data with other companies for non-clinical purposes',\n",
       " 'Opportunistic Salpingectomy by Adoption: Hysterectomy Procedures',\n",
       " 'Opportunistic Salpingectomy by Adoption: Sterilization Procedures',\n",
       " '2 year survival combined cancer sites',\n",
       " '2 year survival endometrial cancer',\n",
       " '2 year survival ovarian cancer',\n",
       " '2 year survival cervical cancer',\n",
       " '2 year survival vulvar cancer',\n",
       " '2 year survival vaginal cancer',\n",
       " '1-minute Apgar score',\n",
       " '5-minute Apgar score',\n",
       " 'Color Apgar at 1 minute',\n",
       " 'Neonatal intensive care unit admission for full-term neonates',\n",
       " 'likelihood of ever testing for biomarkers in epithelial ovarian cancer',\n",
       " 'Clinical in vitro fertilization outcomes within state insurance mandate status group, 2014-2019: Cumulative Live Birth',\n",
       " 'Clinical in vitro fertilization outcomes within state insurance mandate status group, 2014-2019: Live Birth Among Cycle Starts',\n",
       " 'Clinical in vitro fertilization outcomes within state insurance mandate status group, 2014-2019: Live Birth Among Embryo Transfers',\n",
       " 'Clinical in vitro fertilization outcomes within state insurance mandate status group, 2014-2019: Live Birth among Embryo Transfers',\n",
       " 'Clinical in vitro fertilization outcomes within state insurance mandate status group, 2014-2019: Clinical Pregnancy among Cycle Starts',\n",
       " 'Clinical in vitro fertilization outcomes within state insurance mandate status group, 2014-2019: Clinical Pregnancy among Embryo Transfers',\n",
       " 'Clinical in vitro fertilization outcomes within state insurance mandate status group, 2014-2019: Spontaneous Abortion',\n",
       " 'Clinical in vitro fertilization outcomes within state insurance mandate status group, 2014-2019: Cycle Cancellation',\n",
       " 'all-cause 30-day rehospitalization',\n",
       " 'RN pain reassessment non-compliance proportions',\n",
       " 'trichomonas vaginalis positivity',\n",
       " 'women who were re-tested within 90 days after a positive index test',\n",
       " 'Indication for oocyte cryopreservation - Fertility preservation (not otherwise specified) or no reason given',\n",
       " 'Indication for oocyte cryopreservation - diminished ovarian reserve',\n",
       " 'Indication for oocyte cryopreservation - infertility diagnosis',\n",
       " 'Indication for oocyte cryopreservation - gonadotoxic therapy',\n",
       " 'Indication for oocyte cryopreservation - Fertility perservation, medical reason',\n",
       " 'Indication for oocyte cryopreservation - Other',\n",
       " 'Gonadotropin dose > 4000 IU',\n",
       " 'Cycle cancellation',\n",
       " 'Hyperstimulation',\n",
       " 'number of oocytes retrieved',\n",
       " 'mature oocytes',\n",
       " 'Fertility preferences have changed due to the pandemic',\n",
       " 'Trying to conceive later',\n",
       " 'clinical loss',\n",
       " 'Clinical pregnancy',\n",
       " 'initial infertility consultation vs. no-showed and cancelled',\n",
       " 'Black race',\n",
       " 'Survival time in months',\n",
       " 'all-cause death',\n",
       " 'ovarian cancer-specific death',\n",
       " 'Census demographics',\n",
       " 'age-standardized five-year net survival',\n",
       " 'cancer-directed surgery',\n",
       " 'radiotherapy',\n",
       " 'systemic therapy',\n",
       " 'not getting chemotherapy recommendations',\n",
       " 'receiving standard of care treatment',\n",
       " 'initial National Comprehensive Cancer Network distress score',\n",
       " 'initial National Comprehensive Cancer Network distress score = 0',\n",
       " 'reached referral threshold (initial National Comprehensive Cancer Network distress score >= 4)',\n",
       " 'declined resources at initial encounter',\n",
       " 'number of National Comprehensive Cancer Network problem list problems checked (total)',\n",
       " 'number of National Comprehensive Cancer Network problem list problems checked (practical)',\n",
       " 'number of National Comprehensive Cancer Network problem list problems checked (family)',\n",
       " 'number of National Comprehensive Cancer Network problem list problems checked (emotional)',\n",
       " 'number of National Comprehensive Cancer Network problem list problems checked (spiritual)',\n",
       " 'number of National Comprehensive Cancer Network problem list problems checked (physical)',\n",
       " 'Enrollment in poly(ADP-ribose) polymerase inhibitor clinical trials',\n",
       " 'Microbiota in endometrial tumors - Actinobacteria phylum',\n",
       " 'Microbiota in endometrial tumors - Bacteroidetes phylum',\n",
       " 'Microbiota in endometrial tumors - Cyanobacteria phylum',\n",
       " 'Microbiota in endometrial tumors - Firmicutes phylum',\n",
       " 'Microbiota in endometrial tumors - OD1 phylum',\n",
       " 'Microbiota in endometrial tumors - Proteobacteria phylum',\n",
       " 'Microbiota in endometrial tumors - Acidovorax genus',\n",
       " 'Microbiota in endometrial tumors - Acinetobacter genus',\n",
       " 'Microbiota in endometrial tumors - Brachybacterium genus',\n",
       " 'Microbiota in endometrial tumors - Bradyrhizobium genus',\n",
       " 'Microbiota in endometrial tumors - Brevibacterium genus',\n",
       " 'Microbiota in endometrial tumors - Brevundimonas genus',\n",
       " 'Microbiota in endometrial tumors - Candidatus Rhodoluna genus',\n",
       " 'Microbiota in endometrial tumors - Corynebacterium genus',\n",
       " 'Microbiota in endometrial tumors - Delftia genus',\n",
       " 'Microbiota in endometrial tumors - Dietzia genus',\n",
       " 'Microbiota in endometrial tumors - Flavobacterium genus',\n",
       " 'Microbiota in endometrial tumors - Geobacillus genus',\n",
       " 'Microbiota in endometrial tumors - Hyphomicrobium genus',\n",
       " 'Microbiota in endometrial tumors - Methylobacterium genus',\n",
       " 'Microbiota in endometrial tumors - Paenibacillus genus',\n",
       " 'Microbiota in endometrial tumors - Pelomonas genus',\n",
       " 'Microbiota in endometrial tumors - Prevotella genus',\n",
       " 'Microbiota in endometrial tumors - Propionibacterium genus',\n",
       " 'Microbiota in endometrial tumors - Pseudomonas genus',\n",
       " 'Microbiota in endometrial tumors - Ralstonia genus',\n",
       " 'Microbiota in endometrial tumors - Rhodobacter genus',\n",
       " 'Microbiota in endometrial tumors - Sediminibacterium genus',\n",
       " 'Microbiota in endometrial tumors - Staphylococcus genus',\n",
       " 'Microbiota in endometrial tumors - Stenotrophomonas genus',\n",
       " 'Microbiota in endometrial tumors - Streptococcus genus',\n",
       " 'Microbiota in endometrial tumors - Tepidimonas genus',\n",
       " 'readmission risk among women with endometrial cancer',\n",
       " 'hospitalization for COVID-19',\n",
       " 'death within 30 days after COVID-19 diagnosis',\n",
       " 'Up-to-date cervical cancer screening rates among American Indian/Alaska Native women in the Pacific Northwest',\n",
       " 'Rates of HPV vaccination initiation among American Indian/Alaska Native Youth in the Pacific Northwest, 2019',\n",
       " 'Rates of completed HPV vaccination series among American Indian/Alaska Native Youth in the Pacific Northwest, 2019',\n",
       " 'overall mortality',\n",
       " 'endometrial cancer mortality: all histologic subtypes',\n",
       " 'endometrial cancer mortality: high-grade endometrioid carcinoma',\n",
       " 'endometrial cancer mortality: nonendometrioid carcinoma',\n",
       " 'overall mortality: all histologic subtypes',\n",
       " 'overall mortality: high-grade endometrioid carcinoma',\n",
       " 'overall mortality: nonendometrioid carcinoma',\n",
       " 'Sentinel lymph node biopsy for early-stage vulvar cancer',\n",
       " 'Total cases 1975-2017',\n",
       " 'age of diagnosis',\n",
       " 'Total Potential Years of Life Lost',\n",
       " 'Potential Years of Life Lost',\n",
       " 'Total Cases 1975-2017',\n",
       " 'Complications at all during primary stay',\n",
       " 'Grade ≥ 3 complications during primary stay',\n",
       " 'Complications at all after primary stay (within 30 days)',\n",
       " 'Grade ≥ 3 complications after primary stay',\n",
       " '30-day mortality after surgery',\n",
       " 'Reoperation (during primary stay or within 30 days)',\n",
       " 'ICU Transfer (during primary stay or within 30 days)',\n",
       " 'Readmission within 30 days',\n",
       " 'surgery refusal',\n",
       " 'Clinical Trial Participation in Ovarian Cancer',\n",
       " 'Educational Themed Content',\n",
       " 'DISCERN Scale',\n",
       " 'MED12 mutations in leiomyoma',\n",
       " 'non-MED12 mutations in leiomyoma',\n",
       " 'c.130-c.131 missense mutations G>T',\n",
       " 'c.130-c.131 missense mutations G>C',\n",
       " 'c.130-c.131 missense mutations G>A',\n",
       " 'Adherence to national comprehensive cancer network treatment guidelines',\n",
       " '30-Day Major Postoperative Complications',\n",
       " 'laparoscopic myomectomy approach',\n",
       " 'complication occurrence',\n",
       " 'complication occurrence - serious complication',\n",
       " 'individual complication occurrence - transfusion',\n",
       " 'individual complication occurrence - wound infection',\n",
       " 'individual complication occurrence - UTI',\n",
       " 'individual complication occurrence - any infection',\n",
       " 'individual complication occurrence - reoperation',\n",
       " 'individual complication occurrence - sepsis',\n",
       " 'individual complication occurrence - sepsis-shock',\n",
       " 'Cesarean birth (any indication)',\n",
       " 'Cesarean birth - Non-reassuring fetal status',\n",
       " 'Cesarean birth - Labor dystocia',\n",
       " 'Cesarean birth - Other',\n",
       " 'Maternal morbidity composite',\n",
       " 'Maternal morbidity composite- Transfusion ≥ 4u pRBC',\n",
       " 'Maternal morbidity composite- Transfusion any other products',\n",
       " 'Maternal morbidity composite- Postpartum infection',\n",
       " 'Maternal morbidity composite- ICU admission',\n",
       " 'Maternal morbidity composite- Hysterectomy',\n",
       " 'Maternal morbidity composite- Venous thromboembolism',\n",
       " 'Neonatal outcomes- Small for gestational age',\n",
       " 'Neonatal outcomes- NICU admission',\n",
       " 'Neonatal outcomes- 1-minute Apgar ≥ 7',\n",
       " 'Cesarean birth',\n",
       " 'Cesarean indication- Non-reassuring fetal status',\n",
       " 'Cesarean indication- Labor Dystocia',\n",
       " 'Cesarean indication- Other',\n",
       " 'Maternal morbidity composite- Adjusted for cesarean birth',\n",
       " 'Drug-related death during or within 1 year of pregnancy',\n",
       " 'Death by suicide during or within 1 year of pregnancy',\n",
       " 'Death by homicide during or within 1 year of pregnancy',\n",
       " 'Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) seropositivity at the end of pregnancy',\n",
       " 'Racial and ethnic disparity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity at the end of pregnancy mediated by neighborhood deprivation',\n",
       " 'Racial and ethnic disparity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity at the end of pregnancy mediated by neighborhood segregation',\n",
       " 'Racial and ethnic disparity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity at the end of pregnancy mediated by residential crowding',\n",
       " 'cannabis users advised not to breastfeed',\n",
       " 'cannabis users advised not to breastfeed with self-reported prenatal cannabis use',\n",
       " 'Antenatal depression screen completion',\n",
       " 'Antenatal depression treatment recommendation',\n",
       " 'enrollment in precision oncology clinical trials for gynecologic cancers',\n",
       " 'Composite neonatal adverse outcome',\n",
       " '5-min Apgar score less than 5',\n",
       " 'Assisted ventilation longer than 6 h',\n",
       " 'Neonatal seizure',\n",
       " 'Neonatal death',\n",
       " 'Infant death',\n",
       " 'Composite maternal adverse outcome',\n",
       " 'Admission to ICU',\n",
       " 'Maternal transfusion',\n",
       " 'Uterine rupture',\n",
       " 'Unplanned hysterectomy',\n",
       " 'Composite maternal adverse outcome without transfusion',\n",
       " 'composite adverse pregnancy outcome',\n",
       " 'Hypertensive disorders of pregnancy',\n",
       " 'Small for gestational age',\n",
       " 'Fertility-Sparing Treatment',\n",
       " 'Uninsurance at Birth',\n",
       " 'Permanent Contraception Fulfillment at Hospital Discharge',\n",
       " 'Permanent Contraception Fulfillment at 42 Days Postpartum',\n",
       " 'Permanent Contraception Fulfillment at 365 Days Postpartum',\n",
       " 'Ovarian cancer - All histotypes',\n",
       " 'Ovarian cancer - High-grade serous',\n",
       " 'Ovarian cancer - Low-grade serous',\n",
       " 'Ovarian cancer - Endometrioid',\n",
       " 'Ovarian cancer - Clear cell',\n",
       " 'Ovarian cancer - Mucinous',\n",
       " 'Ovarian cancer - Low-grade, serous, endometroid, and clear cell',\n",
       " 'Ovarian cancer',\n",
       " 'Fully Vaccinated Before Pregnancy',\n",
       " 'Received Inpatient Vaccination',\n",
       " 'third or fourth degree perineal laceration',\n",
       " 'Cardiovascular-related outcomes: Composite Outcome',\n",
       " 'Cardiovascular-related outcomes: New Hypertension',\n",
       " 'Cardiovascular-related outcomes: Metabolic Disorder',\n",
       " 'Pregestational diabetes',\n",
       " 'Gestational diabetes',\n",
       " 0.0,\n",
       " 1.0]"
      ]
     },
     "execution_count": 167,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get unique values from the outcome and health_outcome columns\n",
    "unique_outcomes = df['outcome'].dropna().unique()\n",
    "unique_health_outcomes = df['health_outcome'].dropna().unique()\n",
    "\n",
    "# Combine and deduplicate the lists\n",
    "all_outcomes = pd.Series(list(unique_outcomes) + list(unique_health_outcomes)).dropna().unique().tolist()\n",
    "all_outcomes\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "id": "bca313a9-eb44-4ccc-8976-99e4a7ac92d3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import re\n",
    "\n",
    "# Broad categories and associated keywords to classify outcomes\n",
    "category_keywords = {\n",
    "    'Maternal': ['maternal', 'cesarean', 'pregnancy-related mortality', 'hysterectomy', 'uterine', 'pregnancy', 'transfusion', 'ICU', 'perineal', 'postpartum'],\n",
    "    'Neonatal': ['neonatal', 'birthweight', 'NICU', 'apgar', 'infant', 'small for gestational age', 'preterm'],\n",
    "    'Fertility / ART': ['fertility', 'ivf', 'in vitro', 'oocyte', 'assisted reproductive', 'cryopreservation', 'gonadotropin', 'cycle', 'embryo'],\n",
    "    'Cancer': ['cancer', 'chemotherapy', 'oncology', 'tumor', 'nccn', 'radiotherapy', 'survival'],\n",
    "    'Mental Health': ['depression', 'stress', 'mental health'],\n",
    "    'COVID-19': ['covid', 'sars-cov-2', 'coronavirus'],\n",
    "    'Access & Experience': ['insurance', 'access', 'care', 'pain', 'disparity', 'recommendation letters'],\n",
    "    'Other': []  # default category for anything not matching above\n",
    "}\n",
    "\n",
    "# Function to categorize outcomes\n",
    "def categorize_outcome(outcome):\n",
    "    outcome_lower = str(outcome).lower()\n",
    "    for category, keywords in category_keywords.items():\n",
    "        if any(re.search(rf\"\\b{kw}\\b\", outcome_lower) for kw in keywords):\n",
    "            return category\n",
    "    return 'Other'\n",
    "\n",
    "# Combine and deduplicate all outcomes\n",
    "unique_outcomes = pd.Series(df['outcome'].dropna().tolist() + df['health_outcome'].dropna().tolist()).dropna()\n",
    "categorized = unique_outcomes.apply(categorize_outcome)\n",
    "\n",
    "# Count instances per category\n",
    "category_counts = categorized.value_counts()\n",
    "\n",
    "# Plot a bubble chart\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(x=range(len(category_counts)), y=[1]*len(category_counts), \n",
    "            s=category_counts.values * 30, alpha=0.6)\n",
    "\n",
    "for i, (cat, count) in enumerate(category_counts.items()):\n",
    "    plt.text(i, 1, f'{cat}\\n({count})', ha='center', va='center', fontsize=10)\n",
    "\n",
    "plt.axis('off')\n",
    "plt.title(\"Prevalence of Health Outcome Categories in Studies\", fontsize=14)\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 170,
   "id": "7c473d24-02ae-4cf7-b5e1-2fdd9b393d82",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Collect all racial group values from race columns\n",
    "race_values = pd.Series(dtype=str)\n",
    "\n",
    "for col in race_columns:\n",
    "    race_values = pd.concat([race_values, df[col].dropna().astype(str)])\n",
    "\n",
    "# Count occurrences of each racial group label\n",
    "race_counts = race_values.value_counts().sort_values(ascending=False)\n",
    "\n",
    "# Plot\n",
    "plt.figure(figsize=(10, 6))\n",
    "race_counts.head(15).plot(kind='barh', alpha=0.8)\n",
    "plt.xlabel(\"Number of Comparisons\")\n",
    "plt.title(\"Most Frequently Compared Racial Groups\")\n",
    "plt.gca().invert_yaxis()\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 173,
   "id": "5c16ae00-e7ec-4676-a966-579260563ed8",
   "metadata": {},
   "outputs": [],
   "source": [
    "import plotly.express as px\n",
    "import dash\n",
    "from dash import dcc, html, Input, Output, ctx\n",
    "from wordcloud import WordCloud\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import base64\n",
    "from io import BytesIO\n",
    "import plotly.graph_objects as go"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 183,
   "id": "d1f34643-7ee0-4248-baf5-a29d7e3bd838",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "        <iframe\n",
       "            width=\"100%\"\n",
       "            height=\"650\"\n",
       "            src=\"http://127.0.0.1:8090/\"\n",
       "            frameborder=\"0\"\n",
       "            allowfullscreen\n",
       "            \n",
       "        ></iframe>\n",
       "        "
      ],
      "text/plain": [
       "<IPython.lib.display.IFrame at 0x1ff7a5c8e00>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from dash import Dash, html, dcc, Input, Output\n",
    "import plotly.express as px\n",
    "import pandas as pd\n",
    "\n",
    "# Assume df is already loaded\n",
    "\n",
    "app = Dash(__name__)\n",
    "\n",
    "# --- Preprocess data for dropdown and plots ---\n",
    "all_races = ['All'] + sorted(df['race1_clean'].dropna().unique().tolist())\n",
    "\n",
    "category_counts_all = df['health_category'].value_counts().reset_index()\n",
    "category_counts_all.columns = ['health_category', 'count']\n",
    "\n",
    "# --- Layout ---\n",
    "app.layout = html.Div([\n",
    "    html.H2(\"Health Outcome Categories by Race\"),\n",
    "\n",
    "    html.Div([\n",
    "        html.Label(\"Select Racial Group:\"),\n",
    "        dcc.Dropdown(\n",
    "            id='race-selector',\n",
    "            options=[{'label': race, 'value': race} for race in all_races],\n",
    "            value='All',\n",
    "            clearable=False\n",
    "        )\n",
    "    ], style={'width': '30%', 'marginBottom': '20px'}),\n",
    "\n",
    "    dcc.Graph(id='category-bubble-chart'),\n",
    "\n",
    "    html.H4(\"Top 10 Health Outcomes in Selected Category\"),\n",
    "    dcc.Graph(id='top-outcomes-bar'),\n",
    "\n",
    "    html.H4(\"Proportional Distribution of Health Categories by Race\"),\n",
    "    dcc.Graph(id='stacked-bar-chart'),\n",
    "\n",
    "    html.H4(\"Heatmap of Health Category Prevalence by Race\"),\n",
    "    dcc.Graph(id='heatmap')\n",
    "])\n",
    "\n",
    "# --- Callbacks ---\n",
    "@app.callback(\n",
    "    Output('category-bubble-chart', 'figure'),\n",
    "    Input('race-selector', 'value')\n",
    ")\n",
    "def update_bubble_chart(selected_race):\n",
    "    if selected_race == 'All':\n",
    "        data = df\n",
    "    else:\n",
    "        data = df[df['race1_clean'] == selected_race]\n",
    "\n",
    "    category_counts = data[data['health_category'] != 'Other']['health_category'].value_counts().reset_index()\n",
    "    category_counts.columns = ['health_category', 'count']\n",
    "\n",
    "    fig = px.scatter(\n",
    "        category_counts,\n",
    "        x='health_category', y=[1]*len(category_counts),\n",
    "        size='count', color='count', text='health_category',\n",
    "        size_max=100, height=400, color_continuous_scale='Viridis_r'\n",
    "    )\n",
    "    fig.update_traces(textposition='middle center')\n",
    "    fig.update_layout(\n",
    "        showlegend=False,\n",
    "        xaxis_title='', yaxis_title='',\n",
    "        yaxis=dict(showticklabels=False),\n",
    "        title=\"Prevalence of Health Outcome Categories\"\n",
    "    )\n",
    "    return fig\n",
    "\n",
    "@app.callback(\n",
    "    Output('top-outcomes-bar', 'figure'),\n",
    "    Input('race-selector', 'value')\n",
    ")\n",
    "def update_outcomes_bar(selected_race):\n",
    "    if selected_race == 'All':\n",
    "        data = df\n",
    "    else:\n",
    "        data = df[df['race1_clean'] == selected_race]\n",
    "\n",
    "    outcome_counts = data['outcome'].value_counts().head(10).reset_index()\n",
    "    outcome_counts.columns = ['outcome', 'count']\n",
    "    outcome_counts = outcome_counts.sort_values('count', ascending=True)\n",
    "\n",
    "    fig = px.bar(\n",
    "        outcome_counts,\n",
    "        x='count', y='outcome', orientation='h',\n",
    "        color='count', color_continuous_scale='Viridis_r'\n",
    "    )\n",
    "    fig.update_layout(title=\"Top 10 Health Outcomes\", yaxis_title=\"Outcome\", xaxis_title=\"Count\")\n",
    "    return fig\n",
    "\n",
    "@app.callback(\n",
    "    Output('stacked-bar-chart', 'figure'),\n",
    "    Input('race-selector', 'value')\n",
    ")\n",
    "def update_stacked_bar(selected_race):\n",
    "    data = df[df['health_category'] != 'Other']\n",
    "\n",
    "    if selected_race != 'All':\n",
    "        data = data[data['race1_clean'] == selected_race]\n",
    "\n",
    "    grouped = data.groupby(['race1_clean', 'health_category']).size().reset_index(name='count')\n",
    "    total_per_race = grouped.groupby('race1_clean')['count'].transform('sum')\n",
    "    grouped['percent'] = (grouped['count'] / total_per_race) * 100\n",
    "\n",
    "    fig = px.bar(\n",
    "        grouped,\n",
    "        x='race1_clean', y='percent', color='health_category',\n",
    "        title=\"Health Category Composition by Race (Proportional)\",\n",
    "        labels={'percent': 'Percent (%)', 'race1_clean': 'Race'},\n",
    "        height=400\n",
    "    )\n",
    "    fig.update_layout(barmode='stack')\n",
    "    return fig\n",
    "\n",
    "\n",
    "@app.callback(\n",
    "    Output('heatmap', 'figure'),\n",
    "    Input('race-selector', 'value')\n",
    ")\n",
    "def update_heatmap(selected_race):\n",
    "    data = df[df['health_category'] != 'Other']\n",
    "\n",
    "    if selected_race != 'All':\n",
    "        data = data[data['race1_clean'] == selected_race]\n",
    "\n",
    "    heatmap_data = data.groupby(['race1_clean', 'health_category']).size().reset_index(name='count')\n",
    "    pivot = heatmap_data.pivot(index='race1_clean', columns='health_category', values='count').fillna(0)\n",
    "\n",
    "    fig = px.imshow(\n",
    "        pivot,\n",
    "        text_auto=True,\n",
    "        labels=dict(x=\"Health Category\", y=\"Race\", color=\"Count\"),\n",
    "        title=\"Heatmap of Health Category Prevalence by Race\",\n",
    "        aspect=\"auto\",\n",
    "        height=500\n",
    "    )\n",
    "    return fig\n",
    "\n",
    "# --- Run App ---\n",
    "if __name__ == '__main__':\n",
    "    app.run(port=8090, debug=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "712c7d97-9101-4f52-87b7-24df1dc37ab4",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:base]",
   "language": "python",
   "name": "conda-base-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
